Linvoseltamab
Regeneron
['linker,mm,3', 'linker-mm1', 'multiple myeloma']
learn about a linker-mm1 study for patients with relapsed/refractory multiple myeloma during this oral abstract session. #researchcurescancer #asco23 : 2:15 p.m. edt/1:15 p.m. cdt : hall d2 
Indiana University Melvin and Bren Simon Comprehensive Cancer Center | The state's only NCI-designated comprehensive cancer center | A leader in cancer research